Daily Endocrinology Research Analysis
Three impactful endocrinology studies stand out today: a Nature Communications analysis linking genetic architecture of food-liking traits to cardio-metabolic diseases, a large prospective cohort showing the timing of physical activity associates with type 2 diabetes risk, and a meta-analysis indicating 1-hour postprandial glucose targets may reduce large-for-gestational-age risk in gestational diabetes. Together, they advance precision nutrition, chrono-lifestyle strategies, and pragmatic glyce
Summary
Three impactful endocrinology studies stand out today: a Nature Communications analysis linking genetic architecture of food-liking traits to cardio-metabolic diseases, a large prospective cohort showing the timing of physical activity associates with type 2 diabetes risk, and a meta-analysis indicating 1-hour postprandial glucose targets may reduce large-for-gestational-age risk in gestational diabetes. Together, they advance precision nutrition, chrono-lifestyle strategies, and pragmatic glycemic targets.
Research Themes
- Genetics-informed nutrition and cardio-metabolic risk
- Chronobiology of physical activity and type 2 diabetes prevention
- Optimizing postprandial glucose targets in gestational diabetes
Selected Articles
1. The health impacts and genetic architecture of food liking in cardio-metabolic diseases.
In an integrative analysis of UK Biobank food-liking traits and large-scale GWAS, liking for bacon and diet fizzy drinks was linked to higher cardio-metabolic risk, whereas liking for broccoli, pizza, and lentils/beans was protective. They identified 54 pleiotropic variants mapping to 251 tissue-specific genes (four highly druggable) and clarified that the diet-fizzy-drinks–heart failure link may be indirect via adiposity-related pathways.
Impact: This study provides mechanistic genetic links between food preferences and cardio-metabolic diseases and nominates druggable targets, advancing precision nutrition beyond observational associations.
Clinical Implications: Clinicians can consider genetic predispositions to certain food preferences when counseling on diet; caution around diet soda and processed meat preferences may be warranted. Findings support development of personalized dietary strategies and potential target pathways for intervention.
Key Findings
- Two detrimental liking traits (bacon, diet-fizzy-drinks) and three protective traits (broccoli, pizza, lentils/beans) were identified for cardio-metabolic outcomes.
- Genetic links were found between diet-fizzy-drinks and heart failure, and between bacon or lentils/beans and type 2 diabetes.
- Fifty-four pleiotropic single-nucleotide variants mapped to 251 tissue-specific genes; four showed high druggability.
- The diet-fizzy-drinks–heart failure association may be indirect via shared variants related to BMI, adiposity, platelet count, and cardio-metabolic traits.
Methodological Strengths
- Large-scale integration of observational (N=182,087) and genetic datasets (N up to ~977,000)
- Systematic identification of pleiotropic variants and tissue-specific gene mapping with druggability assessment
Limitations
- Food-liking traits rely on self-report and may reflect cultural patterns; causality cannot be established by observational preference data alone.
- Predominantly European ancestry cohorts (UK Biobank, FinnGen) may limit generalizability to other populations.
Future Directions: Test genetics-informed dietary interventions in pragmatic trials; validate tissue-specific targets and explore pharmacologic modulation of pathways linked to detrimental food-liking traits.
We evaluated temporal and genetic relationships between 176 food-liking-traits and cardio-metabolic diseases using data from the UK Biobank (N = 182,087) for observational analyses and summary-level GWAS data from FinnGen and other consortia (N = 406,565-977,323) for genetic analyses. Integrating observational and genetic results, we identified two detrimental food-liking-traits (bacon and diet-fizzy-drinks) and three protective food-liking-traits (broccoli, pizza, and lentils/beans). These food-liking-traits are associated with habitual food intake and influence cardio-metabolic proteins and biological processes. Notably, we found three genetic links: diet-fizzy-drinks with heart-failure, bacon with type-2-diabetes, and lentils/beans with type-2-diabetes, identifying 54 pleiotropic single-nucleotide-variants, impacting both phenotypes. Our data show the diet-fizzy-drinks and heart-failure link maybe not direct, as diet-fizzy-drinks liking correlates with sweet food consumption and shares variants linked to BMI, adiposity, platelet count and cardio-metabolic traits. The pleiotropic single-nucleotide-variants map to 251 tissue-specific genes, with four showing high druggability potential, highlighting personalized dietary strategies for cardio-metabolic diseases.
2. Accelerometer-measured chronoactivity and type 2 diabetes risk: A prospective study in UK Biobank participants.
In 89,439 UK Biobank participants with device-measured activity, higher relative activity in late morning and late afternoon associated with 5–10% lower incident T2D risk over 7.8 years. A late-morning activity peak cluster had lower T2D risk versus a midday pattern (HR 0.88), with attenuation after BMI adjustment.
Impact: Introduces chronoactivity as a modifiable dimension of lifestyle linked to T2D risk using objective accelerometry, informing time-specific preventive strategies.
Clinical Implications: For at-risk patients, scheduling physical activity in late morning or late afternoon may confer additional glycemic risk reduction beyond total activity volume; clinicians can personalize activity timing while awaiting interventional trials.
Key Findings
- Late morning (08:00–10:59) and late afternoon (15:00–15:59, 17:00–17:59) relative activity was associated with ~5–10% lower incident T2D risk.
- A late-morning activity peak cluster had lower T2D risk vs. a midday pattern (HR 0.88, 95% CI 0.79–0.98).
- Associations attenuated after BMI adjustment, suggesting partial mediation via adiposity.
- Over 7.8 years of follow-up, 2,240 incident T2D cases occurred among 89,439 participants.
Methodological Strengths
- Objective accelerometer-based exposure measurement in a large prospective cohort
- Time-of-day–resolved analysis using k-means clustering and multivariable Cox models
Limitations
- Observational design precludes causal inference; residual confounding possible.
- Activity timing assessed at baseline period; changes over time and generalizability beyond the UK Biobank demographic may be limited.
Future Directions: Randomized or quasi-experimental trials to test whether prescribing late-morning/late-afternoon activity reduces glycemic deterioration; mechanistic studies on circadian–metabolic alignment.
OBJECTIVE: We assessed whether timing of physical activity, independent from the total activity amount, - which we refer to as chronoactivity - is associated with type 2 diabetes (T2D) risk. METHODS: We included UK Biobank participants with valid accelerometry data (UK, exposure measurement: 2013-2015, follow-up till November 2023) and without diabetes mellitus at baseline (N = 89,439; mean age: 61.7 [SD:7.9] years). Relative hourly physical activity was calculated by dividing the average hourly clock time physical activity by the average hourly physical activity in a week. Participants were categorized into different chronoactivity clusters using k-means cluster analysis on relative hourly physical activity. We used multivariable-adjusted cox-proportional hazard regressions to examine associations between relative hourly physical activity, chronoactivity clusters and T2D, adjusted for potential confounders, including BMI as a potential mediator. RESULTS: Over 7.8 (interquartile range: 7.2 to 8.3) years of follow-up, 2240 participants developed T2D. Higher relative hourly activity amounts during late morning (8:00-10:59) and late afternoon (15:00-15:59, 17:00-17:59) were associated with approximately 5 %-10 % lower T2D risk. Four clusters of chronoactivity patterns were identified, notably: midday (reference), early morning peak, late morning peak, and evening peak. Compared with participants exhibiting a midday pattern, those with a late morning peak had a lower T2D risk (Hazards Ratio: 0.88, 95 %CI: 0.79, 0.98). Overall, all observations attenuated after additional BMI adjustment. CONCLUSIONS: Independent of the total amount of physical activity, specific timing of physical activity represents an additional dimension in T2D risk.
3. One-hour vs Two-hour Postprandial Glucose Targets and Fetomaternal Outcomes in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Across six studies comparing 1-hour <140 mg/dL vs 2-hour <120 mg/dL targets in GDM, LGA risk was lower with the 1-hour target, with no consistent differences in other outcomes. A stricter 1-hour target (<120 mg/dL) increased preterm delivery risk without improving neonatal anthropometrics.
Impact: Synthesizes comparative evidence on widely used PPG targets and highlights a pragmatic 1-hour threshold that may reduce LGA while avoiding harm from overly strict targets.
Clinical Implications: When setting PPG monitoring targets in GDM, consider a 1-hour target of <140 mg/dL to reduce LGA risk. Avoid overly strict 1-hour targets (<120 mg/dL) given the associated increase in preterm delivery; individualized care and confirmatory trials are warranted.
Key Findings
- Compared to 2-hour <120 mg/dL, targeting 1-hour <140 mg/dL reduced LGA risk (OR 0.54, 95% CI 0.32–0.93).
- No consistent differences were observed for macrosomia, birthweight, neonatal hypoglycemia, pre-eclampsia, cesarean section, or insulin requirement.
- A stricter 1-hour target (<120 mg/dL) increased preterm delivery risk (OR 1.62, 95% CI 1.00–2.62) without improving neonatal size outcomes.
Methodological Strengths
- Systematic synthesis directly comparing clinically used 1-hour versus 2-hour PPG targets
- Evaluation of multiple maternal and neonatal outcomes including LGA and preterm delivery
Limitations
- Relatively small number of included studies; potential heterogeneity in diagnostic criteria and treatment protocols.
- Not all studies were randomized; publication bias and residual confounding cannot be excluded.
Future Directions: Prospective randomized trials comparing 1-hour vs 2-hour PPG targets with standardized protocols to confirm effects on LGA and preterm delivery; assess patient-centered outcomes and resource use.
OBJECTIVE: The optimal time and target for postprandial glucose (PPG) measurement in gestational diabetes mellitus (GDM) remain unclear. This systematic review and meta-analysis evaluated whether targeting 1-hour PPG (1 hPG) vs 2-hour PPG (2 hPG) altered fetomaternal outcomes in GDM. METHODS: Studies that compared pregnancy outcomes in women undergoing 1 hPG vs 2 hPG monitoring in GDM were identified through comprehensive search of electronic databases. Primary outcomes analyzed were large-for-gestational age (LGA) and macrosomia. Secondary outcomes included low birthweight (LBW), neonatal intensive-care unit admission, neonatal hypoglycemia, cesarean section (CS), pre-eclampsia, gestational age at delivery, and preterm delivery. RESULTS: Six articles that compared 1 hPG<140 mg/dL (7.8 mmol/L) vs 2 hPG <120 mg/dL (7.2 mmol/L) were analyzed. Additionally, 3 articles that assessed 1 hPG<120 mg/dL vs1 hPG<140 mg/dL were also examined. Targeting 1 hPG<140 mg/dL vs 2 hPG<120 mg/dL significantly lowered the risk of LGA [odds ratio (OR) 0.54; 95% confidence interval (CI): 0.32-0.93; P = .03] but not macrosomia [OR 0.45; 95%CI:0.19-1.06; P = .07]. There was no difference in other parameters such as birthweight [mean difference -61.77g; 95%CI:-152.16-28.62; P = .018], LBW [OR 0.90; 95%CI:0.30-2.68;P = .85], neonatal hypoglycemia [OR 0.60; 95%CI:0.28-1.26; P = .18], gestational age at delivery [mean difference 0.20 weeks; 95%CI:-0.29-0.68; P = .43], CS [OR 0.99; 95%CI:0.46-2.12;P = .97], pre-eclampsia [OR 0.66;95% CI:.22-1.96; P = .46], or need for insulin therapy [OR 1.39; 95%CI:.79-2.43; P = .25]. More intensive 1 hPG target <120 mg/dL vs <140 mg/dl increased the risk of preterm delivery [OR 1.62; 95% CI:1.00-2.62; P = .05], without affecting birthweight, LGA, macrosomia, LBW, and CS. CONCLUSION: Our findings suggest that targeting 1 hPG <140 mg/dL vs 2 hPG<120 mg/dL lowers the risk of LGA, but does not affect other parameters. A stricter target of 1 hPG<120 mg/dL can increase the risk of preterm delivery. Further studies to corroborate these findings are necessary.